Screener
Kymera Therapeutics KYMR Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $124,477 | $357,011 |
| Marketable securities (Note 4) | 566,508 | 491,265 |
| Accounts receivable | 20,000 | — |
| Prepaid expenses and other current assets | 26,280 | 22,938 |
| Total current assets | $737,265 | $871,214 |
| Marketable securities, non-current (Note 4) | 813,901 | 771,158 |
| Property and equipment, net (Note 6) | 39,971 | 43,175 |
| Right-of-use assets, operating leases | 41,100 | 42,351 |
Item 1. Financial Statements.
FAQ
- What is Kymera Therapeutics's prepaid & other current?
- Kymera Therapeutics (KYMR) reported prepaid & other current of $26.28M in Q2 2026.
- How has Kymera Therapeutics's prepaid & other current changed year-over-year?
- Kymera Therapeutics's prepaid & other current increased by 14.9% year-over-year, from $22.88M to $26.28M.
- What is the long-term trend for Kymera Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Kymera Therapeutics's prepaid & other current has grown at a 37.3% compound annual growth rate (CAGR), from $4.7M to $22.94M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Kymera Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude